Adage Capital Management, L.P.

Insider Reports History

Location
Boston, MA
Signature
/s/ Adage Capital Management, L.P.; By: its general partner Adage Capital Partners LLC; By its managing member Robert Atchinson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adage Capital Management, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Praxis Precision Medicines, Inc. 10%+ Owner Common Stock 2,060,175 $288,424,500 $140.00 16 Oct 2025 Indirect
Solid Biosciences Inc. 10%+ Owner Common Stock, $0.001 par value per share 4,248,084 $32,115,515 $7.56 18 Feb 2025 Indirect
ABEONA THERAPEUTICS INC. 10%+ Owner Pre-funded Warrant (right to buy) 2,948,475 $11,999,998 $4.07 07 May 2024 Indirect
EyePoint Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.001 per share ("Common Stock") 5,156,299 18 Apr 2024 Indirect
Praxis Precision Medicines, Inc. 10%+ Owner Title of Security (Instr. 4) 2,374,085 18 Aug 2025 Indirect

Insider Reports Filed by Adage Capital Management, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRAX Praxis Precision Medicines, Inc. 16 Oct 2025 10 +$33,198,124 4 10%+ Owner 17 Oct 2025, 16:10
PRAX Praxis Precision Medicines, Inc. 18 Aug 2025 0 $0 3 10%+ Owner 19 Aug 2025, 16:10
SLDB Solid Biosciences Inc. 18 Feb 2025 1 +$1,909,240 4 10%+ Owner 19 Feb 2025, 16:16
SLDB Solid Biosciences Inc. 18 Feb 2025 0 $0 3 10%+ Owner 19 Feb 2025, 16:15
ABEO ABEONA THERAPEUTICS INC. 07 May 2024 1 +$11,999,998 4 10%+ Owner 08 May 2024, 16:15
EYPT EyePoint Pharmaceuticals, Inc. 18 Apr 2024 0 $0 3 10%+ Owner 22 Apr 2024, 16:15